Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Inflammatory, Insulin-Sensitizing Agent for Treatment of Cognitive Decline Due to Degenerative Dementias

NCT05227820 is registered in ClinicalTrials.gov with Neurological Associates of West Los Angeles as lead sponsor.

NCT NCT05227820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Inflammatory, Insulin-Sensitizing Agent for Treatment of Cognitive Decline Due to Degenerative Dementias
Lead sponsor
Neurological Associates of West Los Angeles
Phase
Phase 2
Overall status
Completed
Start date
January 19, 2022
Completion date
August 20, 2022
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease